Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt No Debt
UNIS's Cash to Debt is ranked higher than
87% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. UNIS: No Debt )
UNIS' s 10-Year Cash to Debt Range
Min: 0.17   Max: No Debt
Current: No Debt

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Revenue Growth (%) -100.00
UNIS's Revenue Growth (%) is ranked lower than
53% of the 274 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. UNIS: -100.00 )
UNIS' s 10-Year Revenue Growth (%) Range
Min: -100   Max: 76.5
Current: -100

-100
76.5
EBITDA Growth (%) -100.00
UNIS's EBITDA Growth (%) is ranked lower than
52% of the 237 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.90 vs. UNIS: -100.00 )
UNIS' s 10-Year EBITDA Growth (%) Range
Min: -100   Max: 150.7
Current: -100

-100
150.7
EPS Growth (%) -100.00
UNIS's EPS Growth (%) is ranked lower than
52% of the 239 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.80 vs. UNIS: -100.00 )
UNIS' s 10-Year EPS Growth (%) Range
Min: -100   Max: 239.1
Current: -100

-100
239.1
» UNIS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

UNIS Guru Trades in Q3 2013

Jim Simons Sold Out
» More
Q4 2013

UNIS Guru Trades in Q4 2013

Paul Tudor Jones 16,021 sh (New)
Jim Simons 291,121 sh (New)
» More
Q1 2014

UNIS Guru Trades in Q1 2014

Paul Tudor Jones Sold Out
Jim Simons Sold Out
» More
Q2 2014

UNIS Guru Trades in Q2 2014

Jim Simons 319,845 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with UNIS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 24.70
UNIS's P/S is ranked lower than
85% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. UNIS: 24.70 )
UNIS' s 10-Year P/S Range
Min: 0   Max: 86.25
Current: 24.7

0
86.25

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.60
UNIS's Price/Median PS Value is ranked higher than
95% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. UNIS: 0.60 )
UNIS' s 10-Year Price/Median PS Value Range
Min: 0.34   Max: 1.93
Current: 0.6

0.34
1.93
Forward Rate of Return (Yacktman) -20.10
UNIS's Forward Rate of Return (Yacktman) is ranked higher than
59% of the 259 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.15 vs. UNIS: -20.10 )
UNIS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 15.7   Max: 30.2
Current: -20.1

15.7
30.2

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:UNS.Australia, UNISZ.USA, 4UL.Germany
Unilife Corporation Limited, formerly Unilife Medical Solutions Limited is an US-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Target customers include pharmaceutical manufacturers, suppliers of medical equipment, healthcare facilities and patients who self-administer prescription medication. Unilife is ISO 13485-certified and has FDA-registered medical device manufacturing facilities in Pennsylvania.
» More Articles for UNIS

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: BH, TRCR, SHOR, IEC, UNIS Feb 10 2012 
Weekly CEO Buys Highlight: BH, TRCR, SHOR, IEC, UNIS Feb 10 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 29 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 28 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 28 2012 
Medical. All insider Jan 24 2012 
Weekly CEO Buys Highlight: TRNO, UNIS, GFN Jan 21 2012 
Weekly CEO Buys Highlight: UNIS, TRNO, WINA, SXC, CTFO Jan 14 2012 
3.31 Jan 12 2012 
Recent Purchase Jan 08 2012 

More From Other Websites
Falling Earnings Estimates Signal Weakness Ahead for Unilife (UNIS) Aug 11 2014
Unilife Completes Use of At-The-Market Financing (ATM) Facility Aug 04 2014
Unilife Completes Use of At-The-Market Financing (ATM) Facility Aug 04 2014
Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers Jul 30 2014
Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers Jul 30 2014
UNILIFE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 30 2014
Unilife Files to Renew Shelf Registration Statement Jun 30 2014
Unilife Files to Renew Shelf Registration Statement Jun 30 2014
Why Unilife (UNIS) Could Be Positioned for a Slump Jun 11 2014
Unilife to Present at the Jefferies 2014 Global Healthcare Conference May 27 2014
Unilife Investors Kept In The Dark (With Help From The SEC) May 27 2014
Moving Average Crossover Alert: Unilife (UNIS) May 23 2014
UNILIFE CORP Financials May 21 2014
Nasdaq stocks posting largest percentage increases May 20 2014
UNILIFE CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... May 14 2014
Unilife Corp's (UNIS) CEO Alan Shortall on Q3 2014 Results - Earnings Call Transcript May 12 2014
UNILIFE CORP Files SEC form 10-Q, Quarterly Report May 12 2014
Unilife sees FY14 revenue $12M-$15M, consensus $21.23M May 12 2014
Unilife reports Q3 EPS (15c), consensus (9c) May 12 2014
Unilife Corporation Announces Financial Results For Fiscal Year 2014 Third Quarter May 12 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide